Sveriges mest populära poddar

PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain

1 tim 19 min•26 augusti 2022

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.

www.psychedelicstoday.com

Fler avsnitt av Psychedelics Today

PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

11 maj•1 tim 44 min

PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium

8 maj•54 min

PT 654 - Erica Rex - Seeing What Is There

23 apr.•1 tim 21 min

PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy

16 apr.•1 tim 19 min

PT 652 - Esme Dark - Psychedelics, Somatics and the Shadow

25 mars•1 tim 14 min

PT 651 - Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

19 mars•1 tim 22 min

PT 650 - Joe Moore Psychedelics Today on Leadership, Integration, and the Psychedelic Landscape

9 mars•1 tim 7 min

PT 649 - Melissa Lavasani and Jay Kopelman

19 feb.•1 tim 10 min

PT 648 - Enamory - Couples Therapy with Ketamine

10 feb.•1 tim 23 min

PT 647 - Joshua White: Fireside Project and Lucy, an AI Training Simulator for Psychedelic Support

22 jan.•1 tim 11 min

Psychedelics Today med Psychedelics Today finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.